Moreover, Wirries A et al. [11] reported that survivin and its downstream target Bcl-2 were suppressed by Panobinostat in osteosarcoma cells, which provide new perspectives for the therapy of osteosarcoma. The gene discussed is BIRC5; the disease is osteosarcoma.